Insulin: basal-bolus more cost effective than premixed for T2DM

Author：

ISSN： 1173-5503

Source： PharmacoEconomics and Outcomes News, Vol.1, Iss.634, 2011-01, pp. : 9-9

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Basal-bolus insulin superior to sliding scale insulin in T2DM

Inpharma, Vol. 1, Iss. 1612, 2007-01 ,pp. : 16-16

Adis International

Access to resources Recommend Favorite

Insulin Detemir Results in Less Weight Gain than NPH Insulin When Used in Basal-Bolus Therapy for Type 2 Diabetes Mellitus, and this Advantage Increases with Baseline Body Mass Index

By Rašlová Katarina

Clinical Drug Investigation, Vol. 27, Iss. 4, 2007-01 ,pp. : 279-285

Adis International

Access to resources Recommend Favorite

Insulin glargine better value than NPH in T2DM

Inpharma, Vol. 1, Iss. 1613, 2007-01 ,pp. : 15-15

Adis International

Access to resources Recommend Favorite

Insulin glargine better value than NPH in T2DM

PharmacoEconomics and Outcomes News, Vol. 1, Iss. 541, 2007-01 ,pp. : 8-8

Adis International

Access to resources Recommend Favorite

Colesevelam add-on therapy cost effective in T2DM

PharmacoEconomics and Outcomes News, Vol. 1, Iss. 613, 2010-01 ,pp. : 6-6

Adis International

Access to resources Recommend Favorite